MHC class H sequences of susceptibility and protection in Mexicans with autoimmune hepatitis

Journal of Hepatology

Volumn 28, Issue 6, 1998, Pages 985-990

  Vázquez García, Miriam Nohemí ^c   Aláez, Carmen ^c   Olivo, Angélica ^c   Debaz, Héctor ^c   Pérez Luque, Elva ^c   Burguete, Ana ^c   Cano, Silvia ^c   De la Rosa, Gabriela ^c   Bautista, Norma ^c   Hernández, Arturo ^c   Bandera, José ^c   Torres, Luis Fernando ^c   Kershenobich, David ^c   Alvarez, Fernando ^a   Gorodezky, Clara ^b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b HOSPITAL GENERAL DE MÉXICO   (Mexico)

^c NONE

Author keywords

Autoimmune hepatitis; Class II; DNA; HLA association; Immunogenetics; MHC; PCR SSO; Shared epitope; Susceptibility

Indexed keywords

HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; VALINE; EPITOPE; HLA D ANTIGEN; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA-DRB1 ANTIGEN;

ADULT; ALLELE; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOCOMPETENCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MEXICO; PRIORITY JOURNAL; T LYMPHOCYTE; AMERICAN INDIAN; CAUCASIAN; DISEASE PREDISPOSITION; GENE; GENETICS; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; INNATE IMMUNITY; METHODOLOGY; POLYMERASE CHAIN REACTION; REFERENCE VALUE; REGRESSION ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADULT; DISEASE SUSCEPTIBILITY; EPITOPES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, MHC CLASS II; HEPATITIS, AUTOIMMUNE; HISTOCOMPATIBILITY TESTING; HLA-D ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; IMMUNITY, NATURAL; INDIANS, NORTH AMERICAN; MALE; MEXICO; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0032092934     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80347-4     Document Type: Article

References (37)

1. Wood JR, Czaja AJ, Beaver SJ. Frequency and significance of double-stranded DNA in chronic active hepatitis. Hepatology. 6:1986;976-980.
2. Toh BH. Smooth muscle autoantibody and autoantigens. Clin Exp Immunol. 24:1976;621-628.
3. Manns MP, Johnson EF, Griffin KJ. Major antigen of liver kidney microsomal antibody in idiopathic autoimmune hepatitis is cytochrome P450dbl. J Clin Invest. 83:1989;1066-1072.
4. Manns MP, Griffin KJ, Sullivan KF, Johnson EF. LKM-1 autoantibodies recognize a short linear sequence in P45011D6, a cytochrome P-450 monooxygenase. J Clin Invest. 88:1991;1370-1378.
5. Treichel U, Poralla T, Hess G, Manns M, Meyer zum Büschenfelde KH. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology. 11:1990;606-612.
6. Treichel U, McFarlane BM, Seki T, Krawitt EL, Alessi N, Stickel F, et al. Demographics of anti-asiaoglycoprotein receptor autoantibodies in autoimmune hepatitis. Gastroenterology. 107:1994;799-804.
7. Abuaf N, Johanet C, Chretien P, Martini E, Soulier E, Laperche S, et al. Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis. Hepatology. 16:1992;892-898.
8. Shuhua H, Tredger M, Gregorio GV, Mieli-Vergani G, Vergani D. Anti-Liver Cytosolic type 1 (LC1) antibodies in childhood autoimmune liver disease. Hepatology. 21:1995;58-62.
9. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde K-H. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet. i:1987;292-294.
10. Wachter B, Kyriatsoulis A, Lohse AW, Gerken G, Meyer zum Büschenfelde K-H, Manns M. Characterization of liver cytokeratin as a major target of antigen of anti-SLA antibodies. J Hepatol. 11:1990;232-239.
11. Czaja AJ, Ming C, Shirai M, Nishioka M. Frequency and significance of antibodies to histones in autoimmune hepatitis. J Hepatol. 23:1995;32-38.
12. Targan SR, Landers C, Vidrich A, Czaja AJ. High-titer anti-neutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis. Gastroenterology. 108:1995;1159-1166.
13. Heard R. HLA and autoimmune disease. Lechler R. HLA and Disease. 1994;123-152 Academic Press, London.
14. Mackay IR, Morris PJ. Association of autoimmune active chronic hepatitis with HLA A1-B8. Lancet. ii:1972;793-795.
15. Mackay IR, Tait BD. HLA associations with autoimmune-type chronic active hepatitis: identification of B8-Drw3 haplotype by family studies. Gastroenterology. 79:1980;95-98.
16. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology. 13:1990;701-706.
17. Czaja JA, Carpenter HA, Cantrach PJ, Moore B. Significance of HLA DR4 in type 1 autoimmune hepatitis. Gastroenterology. 105:1993;1502-1507.
18. Seki T, Kiyosawa K, Inoko K, Ota M. Association of autoimmune hepatitis with HLA- Bw54 and DR4 in Japanese patients. Hepatology. 12:1990;1300-1304.
19. Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K, et al. HLA class II molecules and autimmune hepatitis susceptibility in Japanese patients. Gastroenterology. 103:1992;1041-1047.
20. Doherty DG, Donaldson PT, Underhill JA, Farrant JM, Duthie A, Mieli-Vergani G, et al. Allelic sequence variation in the HLA class II genes and proteins in patients with atoimmune hepatitis. Hepatology. 19:1994;609-615.
21. Stretell MDJ, Donaldson PT, Thomson W, Santrach PJ, Moore SB, Czaja AJ, et al. Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis. Gastroenterology. 112:1997;2028-2035.
22. Fainboim L, Pando M, Larriba J, Goldberg AC, Gorodezky C, Fainboim H, et al. HLA and autoimmune hepatitis. Charron EDK. Proceedings of the 12th IHWC "Genetic Diversity of HLA: Functional and Medical Implications" 1997;418-423. Paris.
23. Marcos Y, Fainbom HA, Capucchio M, Findor J, Daruich J, Reyes B, et al. Two-locus involvement in the association of human leukocyte antigen with the extrahepatic manifestations of autoimmune chronic hepatitis. Hepatology. 19:1994;1371-1374.
24. Gorodezky C. Genetic difference between Europeans and Indians: tissue and blood types. Allergy Proc. 13:1992;243-250.
25. Pekl-Erler ML, Gorodezky C, Layrisse Z, Klitz W, Fainboim L, Vullo C, et al. Anthropology component report for region Latin-America: Amerindian and admixed populations. Charron EDK. Proceedings of the 12th IHWC "Genetic Diversity of HLA: Functional and Medical Implication" 1997;337-344. Paris.
26. Johnson PJ, McFarlane IG. Meeting Report: International Autoimmune Hepatitis Group. Hepatology. 18:1993;998-1005.
27. Yamamoto AM, Cresteil D, Boniface O, Clerc FF, Alvarez F. Identification and analysis of cytochrome P45 II D6 antigenic sites recognized by anti-liver-kidney microsome type 1 antibodies (LKM1). Eur J Immunol. 23:1993;1105-1111.
28. Zachary M, Teresi GA. 2nd ed ASHI Laboratory Manual. 1990;American Society for Histocompatibility and Immunogenetics, Kansas City.
29. Bignon JD, Fernández-Viña M, Arnajz-Villena A, Fauchet R, Weiss E, Powis S, et al. Charron D, Fauchet R. Technical Handbook of the Twelfth International Histocompatibility Workshop. 1996;HLA et Medicine, Paris.
30. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 39:1992;225-235.
31. Svejgaard A, Platz P, Ryder LP. HLA and diseases association: a survey. Immunol Rev. 20:1983;193-217.
32. Tan EM, Cohem As, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthr Rheum. 25:1982;1271-1277.
33. Debaz H, Olivo A, Alaez C, de la Rosa G, Juarez V, Hernández A, et al. Reanalysis of the "shared epitope hypothesis" in rheumatoid arthritis (RA). Allel associations with the disease and with severity, in Mexicans [abstract]. Human Immunol. 44S:1995;63.
34. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predisposition for the immunological features of chronic active hepatitis. Hepatology. 18:1993;816-822.
35. Manabe K, Donaldson PT, Underhill JA, Doherty DG, Mieli-Vergani G, McFarlane IG, et al. Human leukocyte antigen A1-B8-DR3-DQ2-DPB1*0401 extended haplotype in autoimmune hepatitis. Hepatology. 18:1993;1334-1337.
36. Jin-Xiong She. Susceptibility to type I diabetes: HLA-DQ and DR revisited. Immuno Today. 17:1996;323-329.
37. Fu X-T, Bono CP, Woulfe SL, Swearingen C, Summers NL, Sinigaglia F, et al. Pocket 4 of the HI-A-DR(α,β1*0401) molecule is a major determinant of the T cell recognition peptide. J Exp Med. 181:1995;915-926.